Zinc

Zinc supplementation is more clinically nuanced than commonly recognised, with two issues that dominate the practical evidence: the copper interaction at sustained doses above 25 mg/day, and the unreliability of serum zinc as a diagnostic test. The entries in this section cover what the published research shows about forms (picolinate, citrate, gluconate, glycinate), the zinc-copper relationship, zinc carnosine for gut barrier function, and how supplementation should be approached to avoid copper deficiency.

Zinc is essential for immune function, wound repair, taste and smell, hormone synthesis, and the activity of over 300 enzymes. The published research on zinc is unusual in that the most clinically important questions are about avoiding harm at supplemental doses, not about establishing benefit. This makes zinc supplementation a different kind of decision from many other nutrients.

The dominant practical issue is the zinc-copper relationship. Sustained zinc supplementation above approximately 25 mg/day reduces copper absorption through induction of intestinal metallothionein, which traps copper in enterocytes that are then shed. Several published cases of copper deficiency myeloneuropathy have been linked to chronic high-dose zinc use. NHS guidance and the NIH Office of Dietary Supplements both flag this as the principal long-term safety concern for zinc supplementation. Where higher zinc doses are clinically warranted, copper repletion is typically considered alongside.

The second practical issue is testing. Serum zinc is widely available but is a poor marker of zinc status, because plasma zinc is tightly homeostatically regulated and reflects recent intake more than tissue stores. There is no clinically validated alternative biomarker in routine NHS use, which means zinc deficiency is largely a clinical diagnosis rather than a laboratory one.

The questions covered include:

• Forms compared: picolinate, citrate, gluconate, and glycinate (bisglycinate), and the modest absorption differences between them
• Zinc-copper interaction: the mechanism, the dose-rate threshold, and how copper supplementation is typically positioned alongside higher zinc doses
• Zinc carnosine: the evidence for this specific zinc-amino-acid complex on gastric mucosal protection and gut barrier function, where the published research is more developed than for other zinc forms
• Why serum zinc is unreliable as a diagnostic test and what to look at instead in clinical assessment
• Maximum safe long-term doses and the UL position from SACN and NIH ODS
• Compound deficiency patterns where zinc, vitamin A, and protein deficiencies interact to produce disproportionate immune impairment
• Realistic timelines for zinc-related improvements in immune function, skin, and hormones

The marketing around zinc tends to oversell colds-and-flu use, where the evidence is more mixed than the marketing suggests, and underplay the long-term copper interaction. The entries try to give equal weight to both.